2015-07-30 17:41:07 UTC

FDA Clears Two New Devices for Barrett's Treatment

July 30, 2015

New technologies provide endoscopists with more options in treating Barrett’s esophagus.

FDA has provided 510(k) clearance for two new devices from C2 Therapeutics — the Coldplay Cryoballoon Full Ablation System and the Coldplay Cryoballoon Swipe Ablation System. Both devices aim to treat patients with Barrett's esophagus at risk of developing esophageal cancer.

The first device, Coldplay Cryoballoon Ablation System, comprises a through-the-scope balloon catheter that is simultaneously inflated and cooled by an inert refrigerant delivered through a small disposable handheld unit. This device will allow endoscopists to ablate larger areas of tissue in endoscopic applications, in a shorter period of time.

The second technology, the Coldplay Cryoballoon Focal Ablation System, eliminates the need for precise sizing, multiple deployment steps and controller units.

The AGA Center for GI Innovation and Technology is an advocate for new technologies in GI and is pleased to see these new device move forward in an effort to improve patient care. 

More on Barrett's Esophagus

Principles of GI for the NP and PA

Aug. 10, 2018

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

2018 AGA Postgraduate Course

June 2, 2018

Secure your spot for this clinically focused, multi-topic course that offers immediately applicable information. Held in conjunction with DDW®. Save $75 when you register by April 18.

How to Talk with Your Patients About PPIs and Cognitive Decline

Feb. 22, 2018

More information clearing concerns about the use of proton pump inhibitors (PPIs).